PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68 Ga-PSMA-11 PET Using Cyclotron-Produced 68 Ga.

MLA

Thompson, Scott M., et al. “PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68 Ga-PSMA-11 PET Using Cyclotron-Produced 68 Ga.” Hepatology Communications, vol. 6, no. 5, May 2022, pp. 1172–85. EBSCOhost, https://doi.org/10.1002/hep4.1861.

APA

Thompson, S. M., Suman, G., Torbenson, M. S., Chen, Z.-M. E., Jondal, D. E., Patra, A., Ehman, E. C., Andrews, J. C., Fleming, C. J., Welch, B. T., Kurup, A. N., Roberts, L. R., Watt, K. D., Truty, M. J., Cleary, S. P., Smoot, R. L., Heimbach, J. K., Tran, N. H., Mahipal, A., … Goenka, A. H. (2022). PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68 Ga-PSMA-11 PET Using Cyclotron-Produced 68 Ga. Hepatology Communications, 6(5), 1172–1185. https://doi.org/10.1002/hep4.1861

Chicago

Thompson, Scott M, Garima Suman, Michael S Torbenson, Zong-Ming E Chen, Danielle E Jondal, Anurima Patra, Eric C Ehman, et al. 2022. “PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68 Ga-PSMA-11 PET Using Cyclotron-Produced 68 Ga.” Hepatology Communications 6 (5): 1172–85. doi:10.1002/hep4.1861.